St. Petersburg State Public Medical Institution Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2012
NCT01667536
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

St. Petersburg state healthcare institution Mariinsky Outpatient Clinic | St. Petersburg State Public Medical Institution: Clinical Oncological Center

Active Ingredients

Drugs in Phase 2 Trials (2)

99mtc mip 1404 (1 trial)

sodium succinate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 2)

Liver Diseases (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2